Sage Journals: Discover world-class research

Retricted access

Other

First published 2010-02

Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results

G. Comi, P. O'Connor, X. Montalban [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2018

Long-term evaluation of NEDA-3 status in relapsing-remitting multiple sclerosis patients after switching from natalizumab to fingolimod

Lara Diem, Krassen Nedeltchev, Timo Kahles [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2018

NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab versus fingolimod efficacy in multiple sclerosis

Marco Puthenparampil, Chiara Cazzola, Sofia Zywicki [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2018-4

Relapse Rate and MRI Activity in Young Adult Patients With Multiple Sclerosis: A Post Hoc Analysis of Phase 3 Fingolimod Trials

Jutta Gärtner, Tanuja Chitnis, Angelo Ghezzi [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2012-11

Severe multiple sclerosis reactivation under fingolimod 3 months after natalizumab withdrawal

L Daelman, A Maitrot, A Maarouf [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2014-11

The influence of patient demographics,disease characteristics and treatment on brain volume loss in Trial Assessing Injectable Interferon vs FTY720 Oral in Relapsing–Remitting Multiple Sclerosis (TRANSFORMS),a phase 3 study of fingolimod in multiple sclerosis

Frederik Barkhof, Remko de Jong, Nikolaos Sfikas [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2014-10

Fingolimod-associated amenorrhea: a report of three cases

R Alroughani

Multiple Sclerosis Journal

Retricted access

Research article

First published 2012-9

A randomized,controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis

T Saida, S Kikuchi, Y Itoyama [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2023-4

Preserved T cell but attenuated antibody response in MS patients on fingolimod and ocrelizumab following 2nd and 3rd SARS-CoV-2 mRNA vaccine

Sarah Conway, Shrishti Saxena, Clare Baecher-Allan [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2021-5

Tumefactive multiple sclerosis in association with fingolimod initiation and discontinuation

David Croteau, Anne Tobenkin, Allen Brinker [...]

Multiple Sclerosis Journal

Search results